Kalobios Pharmaceuticals, Inc. KBIO

Kalobios Pharmaceuticals, Inc. 3427 Hillview Avenue Palo Alto, CA 94304
Locations Update This Record Cases by Outcome Cases by Type	SEC CIK 1293310

Add a document

Description
Summary
Document Type	Academic Paper Corporate Document - Internal Corporate Document - Public Court Document Equity Research Government Document - Federal Government Document - State Government Document - Local FBI File Public Records Request Response - FOIA Public Records Request Response - State Non-Profit Report Police Report White Paper
Document Date
Document Source
Source URL
File
	If you would like to be credited for contributing this document, make sure to sign in or sign up first. Once uploaded, your document may not be immediately visible to the public as we review each document for legal issues. Thanks for your patience!

Go Pro to view an analysis and graphs of case roles, types and more.

Filter By From To

	Date Filed	Venue	Case Number	Title	Party Type
	7/12/2017	Delaware District Court	1:17-cv-00940	Kalobios Pharmaceuticals, Inc. v. Savant Neglected Diseases,...	Plaintiff
	1/7/2016	Delaware Bankruptcy Court	16-50001	Kalobios Pharmaceuticals, Inc.- Adversary Proceeding	Defendant
	12/31/2015	California Northern District Court	3:15-cv-06331	Isensee v. KaloBios Pharmaceuticals, Inc. et al	Defendant
	12/29/2015	Delaware Bankruptcy Court	15-12628	Kalobios Pharmaceuticals, Inc.	Debtor
	12/23/2015	California Northern District Court	3:15-cv-05992	Sciabacucchi v. KaloBios Pharmaceuticals, Inc. et al	Defendant
	12/18/2015	California Northern District Court	3:15-cv-05841	In Re: KALOBIOS PHARMACEUTICALS, INC. SECURITIES LITIGATION	Defendant
	9/19/2014	New York Southern District Court	1:14-cv-07640	Donoghue et al v. Retrophin, Inc. et al	Miscellaneous

7 Rows Total

Inside Counsel (1)

Go Pro to view corporate inside counsel.

Outside Counsel (18)

	Last Name	First Name	Middle Name	Firm	Location
	Beck	John	Douglas	Hogan Lovells US LLP	New York, NY
	Berney-key	Susan		Cooley LLP	Palo Alto, CA
	Cohen	Mark	S.	Pearl Cohen Zedek & Latzer, LLP	New York, NY
	Harvey	Matthew	B.	Morris, Nichols, Arsht & Tunnell LLP	Wilmington, DE
	Holbert	Lynn	Williams	Hogan Lovells LLP
	Hunter	Travis	Steven	Richards, Layton & Finger, PA	Wilmington, DE
	Ivanick	Peter	A.	Law Offices of Peter A Ivanick	New York, NY
	Kumamoto	Andrew	Aizo	McDermott, Will & Emery, LLP	Ca,
	Lockyer	Jean		Kilpatrick Townsend & Stockton, LLP	SAN FRANCISCO, CA
	Lockyer	Juan	M.	Kilpatrick Townsend & Stockton, LLP
	McLaughlin	Marcy	J.	Morris, Nichols, Arsht & Tunnell LLP	Wilmington, DE
	Mitchell	J.	Christopher	Hogan Lovells LLP	Palo Alto, CA
	Schmidt	Lisa	A.	Richards, Layton & Finger, PA
	Schray	Kerri	Pollard
	Schwartz	Eric	D.	Morris, Nichols, Arsht & Tunnell LLP	Wilmington, DE
	Tol	Pieter	Van	Law Offices of Pieter Van Tol	New York, NY
	Van	Pieter	H.b.	Hogan Lovells LLP	New York, NY
	Werkheiser	Gregory	W.	Morris, Nichols, Arsht & Tunnell LLP	Wilmington, DE

18 Rows Total

Filter By Form All Records 10-12G 10-12G/A 10-K 10-K/A 10-Q 10-Q/A 25-NSE 3 3/A 4 4/A 424B3 424B4 424B5 8-A12B 8-K 8-K/A CERTNAS CORRESP CT ORDER D DEF 14A DEF 14C DEFA14A EFFECT FWP NT 10-K NT 10-Q POS AM PRE 14A PRE 14C PRER14A PRER14C REGDEX S-1 S-1/A S-1MEF S-3 S-8 SC 13D SC 13D/A SC 13G SC 13G/A UPLOAD From To

	Date	Entity	Form Number	Description
	1/8/2024		8-K	Current report pursuant to Section 13 or 15(d)
	10/20/2023	Black Horse Capital, LP	4	Statement of changes in beneficial ownership of securities
	10/12/2023		25-NSE
	9/14/2023		8-K	Current report pursuant to Section 13 or 15(d)
	8/14/2023		NT 10-Q
	7/25/2023		8-K	Current report pursuant to Section 13 or 15(d)
	5/15/2023		10-Q
	4/25/2023		10-K/A
	4/19/2023		8-K	Current report pursuant to Section 13 or 15(d)
	4/6/2023		8-K	Current report pursuant to Section 13 or 15(d)
	3/30/2023		10-K	Annual report pursuant to Section 13 or 15(d)
	3/13/2023		8-K	Current report pursuant to Section 13 or 15(d)
	3/2/2023		8-K	Current report pursuant to Section 13 or 15(d)
	2/24/2023		8-K	Current report pursuant to Section 13 or 15(d)
	2/1/2023		SC 13G/A
	12/22/2022		8-K	Current report pursuant to Section 13 or 15(d)
	11/14/2022		8-K	Current report pursuant to Section 13 or 15(d)
	11/14/2022		10-Q
	10/6/2022		8-K	Current report pursuant to Section 13 or 15(d)
	9/29/2022		8-K	Current report pursuant to Section 13 or 15(d)
	9/2/2022		8-K	Current report pursuant to Section 13 or 15(d)
	8/26/2022		8-K	Current report pursuant to Section 13 or 15(d)
	8/12/2022		8-K	Current report pursuant to Section 13 or 15(d)
	8/12/2022		10-Q
	8/10/2022		SC 13G/A
	7/29/2022	Hohneker John	4	Statement of changes in beneficial ownership of securities
	7/29/2022	Kilcoyne Adrian	4	Statement of changes in beneficial ownership of securities
	7/29/2022	Buxton Cheryl	4	Statement of changes in beneficial ownership of securities
	7/29/2022	Barliant Ronald	4	Statement of changes in beneficial ownership of securities
	7/29/2022	Chappell, Dale	4	Statement of changes in beneficial ownership of securities
	7/29/2022	Boehm Rainer J.	4	Statement of changes in beneficial ownership of securities
	7/29/2022	Edward P. Jordan	4	Statement of changes in beneficial ownership of securities
	7/29/2022	Morris Timothy E	4	Statement of changes in beneficial ownership of securities
	7/29/2022	Xie Yili Kevin	4	Statement of changes in beneficial ownership of securities
	7/29/2022	Durrant, Cameron	4	Statement of changes in beneficial ownership of securities
	7/26/2022		8-K	Current report pursuant to Section 13 or 15(d)
	7/13/2022		8-K	Current report pursuant to Section 13 or 15(d)
	6/30/2022		8-K	Current report pursuant to Section 13 or 15(d)
	6/10/2022		8-K	Current report pursuant to Section 13 or 15(d)
	5/20/2022	Black Horse Capital, LP	4	Statement of changes in beneficial ownership of securities
	5/9/2022		SC 13G
	5/5/2022		8-K	Current report pursuant to Section 13 or 15(d)
	4/14/2022		EFFECT
	4/14/2022		424B5
	4/12/2022		CORRESP
	4/12/2022		DEFA14A
	4/12/2022		DEF 14A
	4/12/2022		8-K	Current report pursuant to Section 13 or 15(d)
	4/12/2022		8-K	Current report pursuant to Section 13 or 15(d)
	3/17/2022		SC 13D/A

721 Rows Total	Page 1 of 15 | Go To

	Date Recorded	Party	Role	Document Type	Document No.	Invention Title
	12/29/2020	Humanigen, Inc.	Assignee	Application Publication Patent	13480937 20130064826 9045539	Anti-emr1 Antibodies Anti-emr1 Antibodies Anti-emr1 Antibodies
	6/5/2020	Humanigen, Inc.	Assignee	Application Application Application Application Application Publication Publication Publication Publication Publication Patent Patent Patent Patent Patent	09764163 12718768 12904953 13571827 14143427 20110123549 20130039907 20140120114 20030165825 20100226930 7544477 8834870 8664365 9109032 9290571	Treatment of Leukemias and Chronic Myeloproliferative Diseases with Anti... Circularly Permutated, Interaction-activated Proteins Antibodies To Epha3 Methods Of Treating Hematological Proliferative Disorders By Targeting E... Antibodies To Epha3 Treatment of Leukemias and Chronic Myeloproliferative Diseases with Anti... Circularly Permutated, Interaction-activated Proteins Antibodies To Epha3 Methods Of Treating Hematological Proliferative Disorders By Targeting E... Antibodies to EphA3 Treatment of Leukemias and Chronic Myeloproliferative Diseases with Anti... Circularly Permutated, Interaction-activated Proteins Antibodies To Epha3 Methods Of Treating Hematological Proliferative Disorders By Targeting E... Antibodies to EphA3
	5/15/2020	Humanigen, Inc.	Assignee	Application Application Publication Publication Patent Patent	12431661 13460151 20090274706 20120213776 8168183 9017674	Antibodies To Granulocyte-macrophage Colony-stimulating Factor Antibodies To Granulocyte-macrophage Colony-stimulating Factor Antibodies To Granulocyte-macrophage Colony-stimulating Factor Antibodies To Granulocyte-macrophage Colony-stimulating Factor Antibodies To Granulocyte-macrophage Colony-stimulating Factor Antibodies To Granulocyte-macrophage Colony-stimulating Factor
	11/6/2017	Humanigen, Inc.	Assignee	Application Publication Patent	11040159 20050255552 7981843	Antibody specificity transfer using minimal essential binding determinan... Antibody specificity transfer using minimal essential binding determinan... Antibody Specificity Transfer Using Minimal Essential Binding Determinan...
	11/6/2017	Humanigen, Inc.	Assignee	Application Publication Patent	12045589 20080286272 8637016	EphA3 Antibodies for the Treatment of Solid Tumors EphA3 Antibodies for the Treatment of Solid Tumors EphA3 Antibodies for the Treatment of Solid Tumors
	11/1/2017	Yarranton, Geoffrey T.	Assignor	Application Publication	15265625 20170226227	Treatment of Leukemias and Chronic Myeloproliferative Diseases with Anti... Treatment of Leukemias and Chronic Myeloproliferative Diseases with Anti...
	11/1/2017	Bebbington, Christopher R.	Assignor	Application Publication	15265625 20170226227	Treatment of Leukemias and Chronic Myeloproliferative Diseases with Anti... Treatment of Leukemias and Chronic Myeloproliferative Diseases with Anti...
	11/1/2017	Palath, Varghese	Assignor	Application Publication	15265625 20170226227	Treatment of Leukemias and Chronic Myeloproliferative Diseases with Anti... Treatment of Leukemias and Chronic Myeloproliferative Diseases with Anti...
	5/23/2016	Black Horse Capital, LP	Assignee	Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application ...and 66 more	11040159 14814179 10365123 12704396 09104340 12045589 13644353 14968709 12419991 13271146 14473821 12431661 13460151 13179304 12718768 09770916 12904953 10544701 14712627 10496059 14143427 12355614 12975214 13164581 10208730 10585149 13480937 ...and 66 more	Method And Compositions For Immunization With The Pseudomonas V Antigen Treatment Of Leukemias And Chronic Myeloproliferative Diseases With Anti... Methods For Affinity Maturation Antibodies To The Pcrv Antigen Of Pseudomonas Aeruginosa Antibodies To Epha3 Secretion of antibodies without signal peptides from bacteria Method And Compositions For Immunization With The Pseudomonas V Antigen Antibodies To Granulocyte-macrophage Colony-stimulating Factor Circularly Permutated, Interaction-activated Proteins Methods Of Treating Heart Failure Using An Anti-gm-csf Antibody Antibodies To Epha3 Secretion Of Antibodies Without Signal Peptides From Bacteria Method Of And Compositions For Immunization With The Pseudomonas V Antig... Immunoglobulin Variable Region Cassette Exchange Generation Of Antibodies To An Epitope Of Interest That Contains A Phosp... EphA3 Antibodies for the Treatment of Solid Tumors Treatment of Leukemias and Chronic Myeloproliferative Diseases with Anti... Methods Of Treating Hematological Proliferative Disorders By Targeting E... Receptor-ligand System And Assay Generation Of Antibodies To An Epitope Of Interest Methods Of Treating Dementia Using A Gm-csf Antagonist Antibodies To Granulocyte-macrophage Colony-stimulating Factor Anti-emr1 Antibodies Chimerized Gm-csf Antibodies Methods of Treating Hematological Proliferative Disorders by Targeting E... Antibody specificity transfer using minimal essential binding determinan... Antibodies To Granulocyte-macrophage Colony-stimulating Factor ...and 66 more
	5/23/2016	Black Horse Capital, LP	Assignee	Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application ...and 67 more	12355614 14143427 13164581 10208730 12975214 10585149 13079641 13480937 13571827 09764163 14677604 11273906 10677131 13506653 11040159 14814179 10365123 12704396 09104340 12045589 13644353 12419991 13271146 14473821 12431661 13460151 13179304 ...and 67 more	Methods Of Treating Hematological Proliferative Disorders By Targeting E... Method And Compositions For Immunization With The Pseudomonas V Antigen Methods Of Treating Chronic Inflammatory Diseases Using A Gm-csf Antagon... Eph/ephrin mediated modulation of cell adhesion and tumour cell metastas... EphA3 Antibodies for the Treatment of Solid Tumors Antibodies to EphA3 Anti-emr1 Antibodies Method Of And Compositions For Immunization With The Pseudomonas V Antig... Immunoglobulin Variable Region Cassette Exchange Generation Of Antibodies To An Epitope Of Interest Methods Of Treating Dementia Using A Gm-csf Antagonist Treatment of Leukemias and Chronic Myeloproliferative Diseases with Anti... Transactivation system for mammalian cells Chimerized Gm-csf Antibodies Methods Of Treating Bone-loss Disorders Using A Gm-csf Antagonist Antibody Specificity Transfer Using Minimal Essential Binding Determinan... Antibodies To Granulocyte-macrophage Colony-stimulating Factor Method Of Treating A Staphylococcus Infection In A Patient Having A Low-... Secretion of antibodies without signal peptides from bacteria Reactivation-based Molecular Interaction Sensors Detection Of Epha3 As A Marker Of The Presence Of A Solid Tumor Methods For Affinity Maturation Antibodies To Granulocyte-macrophage Colony-stimulating Factor Antibodies To Epha3 Secretion Of Antibodies Without Signal Peptides From Bacteria Method And Compositions For Immunization With The Pseudomonas V Antigen Treatment Of Leukemias And Chronic Myeloproliferative Diseases With Anti... ...and 67 more
	3/23/2016	Yarranton, Geoffrey T.	Assignor	Application Publication	14712627 20150246121	Methods Of Treating Chronic Inflammatory Diseases Using A Gm-csf Antagon... Methods Of Treating Chronic Inflammatory Diseases Using A Gm-csf Antagon...
	3/23/2016	Bebbington, Christopher R.	Assignor	Application Publication	14712627 20150246121	Methods Of Treating Chronic Inflammatory Diseases Using A Gm-csf Antagon... Methods Of Treating Chronic Inflammatory Diseases Using A Gm-csf Antagon...
	2/29/2016	Luehrsen, Kenneth	Assignor	Application Publication Patent	14143427 20140120114 9290571	Antibodies To Epha3 Antibodies To Epha3 Antibodies To Epha3
	2/29/2016	Yarranton, Geoffrey T.	Assignor	Application Publication Patent	14143427 20140120114 9290571	Antibodies To Epha3 Antibodies To Epha3 Antibodies To Epha3
	2/29/2016	Martinez, David	Assignor	Application Publication Patent	14143427 20140120114 9290571	Antibodies To Epha3 Antibodies To Epha3 Antibodies To Epha3
	2/29/2016	Bebbington, Christopher R.	Assignor	Application Publication Patent	14143427 20140120114 9290571	Antibodies To Epha3 Antibodies To Epha3 Antibodies To Epha3
	2/29/2016	Yi, Christina	Assignor	Application Publication Patent	14143427 20140120114 9290571	Antibodies To Epha3 Antibodies To Epha3 Antibodies To Epha3
	7/30/2015	Yarranton, Geoffrey T.	Assignor	Application Publication	14814179 20150329647	Methods of Treating Hematological Proliferative Disorders by Targeting E... Methods of Treating Hematological Proliferative Disorders by Targeting E...
	7/30/2015	Baer, Mark	Assignor	Application Publication	14814179 20150329647	Methods of Treating Hematological Proliferative Disorders by Targeting E... Methods of Treating Hematological Proliferative Disorders by Targeting E...
	7/30/2015	Bebbington, Christopher R.	Assignor	Application Publication	14814179 20150329647	Methods of Treating Hematological Proliferative Disorders by Targeting E... Methods of Treating Hematological Proliferative Disorders by Targeting E...
	7/30/2015	Palath, Varghese	Assignor	Application Publication	14814179 20150329647	Methods of Treating Hematological Proliferative Disorders by Targeting E... Methods of Treating Hematological Proliferative Disorders by Targeting E...
	6/26/2015	Luehrsen, Kenneth	Assignor	Application Application Publication Publication Patent	13460151 14677604 20120213776 20150344565 9017674	Antibodies To Granulocyte-macrophage Colony-stimulating Factor Antibodies To Granulocyte-macrophage Colony-stimulating Factor Antibodies To Granulocyte-macrophage Colony-stimulating Factor Antibodies To Granulocyte-macrophage Colony-stimulating Factor Antibodies To Granulocyte-macrophage Colony-stimulating Factor
	6/26/2015	Yarranton, Geoffrey T.	Assignor	Application Application Publication Publication Patent	13460151 14677604 20150344565 20120213776 9017674	Antibodies To Granulocyte-macrophage Colony-stimulating Factor Antibodies To Granulocyte-macrophage Colony-stimulating Factor Antibodies To Granulocyte-macrophage Colony-stimulating Factor Antibodies To Granulocyte-macrophage Colony-stimulating Factor Antibodies To Granulocyte-macrophage Colony-stimulating Factor
	6/26/2015	Bebbington, Christopher R.	Assignor	Application Application Publication Publication Patent	13460151 14677604 20120213776 20150344565 9017674	Antibodies To Granulocyte-macrophage Colony-stimulating Factor Antibodies To Granulocyte-macrophage Colony-stimulating Factor Antibodies To Granulocyte-macrophage Colony-stimulating Factor Antibodies To Granulocyte-macrophage Colony-stimulating Factor Antibodies To Granulocyte-macrophage Colony-stimulating Factor
	10/9/2014	Luehrsen, Kenneth	Assignor	Application Publication	14509437 20150030614	Antibodies To The Pcrv Antigen Of Pseudomonas Aeruginosa Antibodies To The Pcrv Antigen Of Pseudomonas Aeruginosa
	10/9/2014	Yarranton, Geoffrey T.	Assignor	Application Publication	14509437 20150030614	Antibodies To The Pcrv Antigen Of Pseudomonas Aeruginosa Antibodies To The Pcrv Antigen Of Pseudomonas Aeruginosa
	10/9/2014	Baer, Mark	Assignor	Application Publication	14509437 20150030614	Antibodies To The Pcrv Antigen Of Pseudomonas Aeruginosa Antibodies To The Pcrv Antigen Of Pseudomonas Aeruginosa
	10/9/2014	Bebbington, Christopher R.	Assignor	Application Publication	14509437 20150030614	Antibodies To The Pcrv Antigen Of Pseudomonas Aeruginosa Antibodies To The Pcrv Antigen Of Pseudomonas Aeruginosa
	8/29/2014	Yarranton, Geoffrey T.	Assignor	Application Publication	14473821 20140370010	Treatment Of Leukemias And Chronic Myeloproliferative Diseases With Anti... Treatment Of Leukemias And Chronic Myeloproliferative Diseases With Anti...
	8/29/2014	Bebbington, Christopher R.	Assignor	Application Publication	14473821 20140370010	Treatment Of Leukemias And Chronic Myeloproliferative Diseases With Anti... Treatment Of Leukemias And Chronic Myeloproliferative Diseases With Anti...
	8/29/2014	Palath, Varghese	Assignor	Application Publication	14473821 20140370010	Treatment Of Leukemias And Chronic Myeloproliferative Diseases With Anti... Treatment Of Leukemias And Chronic Myeloproliferative Diseases With Anti...
	12/12/2013	Luehrsen, Kenneth R.	Assignor	Application Publication Patent	12864636 20110097326 8642035	Anti-trkb Antibodies Anti-trkb Antibodies Anti-trkb Antibodies
	12/12/2013	Irm LLC	Assignee	Application Publication Patent	12864636 20110097326 8642035	Anti-trkb Antibodies Anti-trkb Antibodies Anti-trkb Antibodies
	1/4/2013	Luehrsen, Kenneth	Assignor	Application Publication	13644353 20130109586	Generation Of Antibodies To An Epitope Of Interest That Contains A Phosp... Generation Of Antibodies To An Epitope Of Interest That Contains A Phosp...
	1/4/2013	Yarranton, Geoffrey T.	Assignor	Application Publication	13644353 20130109586	Generation Of Antibodies To An Epitope Of Interest That Contains A Phosp... Generation Of Antibodies To An Epitope Of Interest That Contains A Phosp...
	1/4/2013	Bai, Lu	Assignor	Application Publication	13644353 20130109586	Generation Of Antibodies To An Epitope Of Interest That Contains A Phosp... Generation Of Antibodies To An Epitope Of Interest That Contains A Phosp...
	1/4/2013	Yi, Christina	Assignor	Application Publication	13644353 20130109586	Generation Of Antibodies To An Epitope Of Interest That Contains A Phosp... Generation Of Antibodies To An Epitope Of Interest That Contains A Phosp...
	11/8/2012	Williams, Jason	Assignor	Application Publication Patent	13480937 20130064826 9045539	Anti-emr1 Antibodies Anti-emr1 Antibodies Anti-emr1 Antibodies
	11/8/2012	Luehrsen, Kenneth	Assignor	Application Publication Patent	13480937 20130064826 9045539	Anti-emr1 Antibodies Anti-emr1 Antibodies Anti-emr1 Antibodies
	11/8/2012	Yarranton, Geoffrey T.	Assignor	Application Publication Patent	13480937 20130064826 9045539	Anti-emr1 Antibodies Anti-emr1 Antibodies Anti-emr1 Antibodies
	11/8/2012	Baer, Mark	Assignor	Application Publication Patent	13480937 20130064826 9045539	Anti-emr1 Antibodies Anti-emr1 Antibodies Anti-emr1 Antibodies
	11/8/2012	Martinez, David	Assignor	Application Publication Patent	13480937 20130064826 9045539	Anti-emr1 Antibodies Anti-emr1 Antibodies Anti-emr1 Antibodies
	11/8/2012	Bebbington, Christopher R.	Assignor	Application Publication Patent	13480937 20130064826 9045539	Anti-emr1 Antibodies Anti-emr1 Antibodies Anti-emr1 Antibodies
	11/8/2012	Palath, Varghese	Assignor	Application Publication Patent	13480937 20130064826 9045539	Anti-emr1 Antibodies Anti-emr1 Antibodies Anti-emr1 Antibodies
	11/8/2012	Tomasevic, Nenad	Assignor	Application Publication Patent	13480937 20130064826 9045539	Anti-emr1 Antibodies Anti-emr1 Antibodies Anti-emr1 Antibodies
	11/8/2012	Sujatha-bhaskar, Swathi	Assignor	Application Publication Patent	13480937 20130064826 9045539	Anti-emr1 Antibodies Anti-emr1 Antibodies Anti-emr1 Antibodies
	10/26/2012	Yarranton, Geoffrey T.	Assignor	Application Publication Patent	13571827 20130039907 9109032	Methods Of Treating Hematological Proliferative Disorders By Targeting E... Methods Of Treating Hematological Proliferative Disorders By Targeting E... Methods Of Treating Hematological Proliferative Disorders By Targeting E...
	10/26/2012	Baer, Mark	Assignor	Application Publication Patent	13571827 20130039907 9109032	Methods Of Treating Hematological Proliferative Disorders By Targeting E... Methods Of Treating Hematological Proliferative Disorders By Targeting E... Methods Of Treating Hematological Proliferative Disorders By Targeting E...
	10/26/2012	Bebbington, Christopher R.	Assignor	Application Publication Patent	13571827 20130039907 9109032	Methods Of Treating Hematological Proliferative Disorders By Targeting E... Methods Of Treating Hematological Proliferative Disorders By Targeting E... Methods Of Treating Hematological Proliferative Disorders By Targeting E...
	10/26/2012	Palath, Varghese	Assignor	Application Publication Patent	13571827 20130039907 9109032	Methods Of Treating Hematological Proliferative Disorders By Targeting E... Methods Of Treating Hematological Proliferative Disorders By Targeting E... Methods Of Treating Hematological Proliferative Disorders By Targeting E...
	5/18/2012	Yu, Bo	Assignor	Application Publication Patent	10585149 20090111144 8354251	Transactivation system for mammalian cells Transactivation system for mammalian cells Transactivation system for mammalian cells
	5/18/2012	Bebbington, Christpher R.	Assignor	Application Publication Patent	10585149 20090111144 8354251	Transactivation system for mammalian cells Transactivation system for mammalian cells Transactivation system for mammalian cells
	9/2/2011	Yarranton, Geoffrey T.	Assignor	Application Publication	13164581 20110318304	Detection Of Epha3 As A Marker Of The Presence Of A Solid Tumor Detection Of Epha3 As A Marker Of The Presence Of A Solid Tumor
	9/2/2011	Baer, Mark	Assignor	Application Publication	13164581 20110318304	Detection Of Epha3 As A Marker Of The Presence Of A Solid Tumor Detection Of Epha3 As A Marker Of The Presence Of A Solid Tumor
	9/2/2011	Bebbington, Christopher R.	Assignor	Application Publication	13164581 20110318304	Detection Of Epha3 As A Marker Of The Presence Of A Solid Tumor Detection Of Epha3 As A Marker Of The Presence Of A Solid Tumor
	9/2/2011	Palath, Varghese	Assignor	Application Publication	13164581 20110318304	Detection Of Epha3 As A Marker Of The Presence Of A Solid Tumor Detection Of Epha3 As A Marker Of The Presence Of A Solid Tumor
	6/15/2011	Bebbington, Christopher R.	Assignor	Application Publication	13078747 20110243934	Epha3 Antibodies For The Treatment Of Multiple Myeloma Epha3 Antibodies For The Treatment Of Multiple Myeloma
	6/15/2011	Palath, Varghese	Assignor	Application Publication	13078747 20110243934	Epha3 Antibodies For The Treatment Of Multiple Myeloma Epha3 Antibodies For The Treatment Of Multiple Myeloma
	6/7/2011	Luehrsen, Kenneth	Assignor	Application Publication	13079641 20110245100	Generation Of Antibodies To An Epitope Of Interest Generation Of Antibodies To An Epitope Of Interest
	6/7/2011	Yarranton, Geoffrey T.	Assignor	Application Publication	13079641 20110245100	Generation Of Antibodies To An Epitope Of Interest Generation Of Antibodies To An Epitope Of Interest
	6/7/2011	Bebbington, Christopher R.	Assignor	Application Publication	13079641 20110245100	Generation Of Antibodies To An Epitope Of Interest Generation Of Antibodies To An Epitope Of Interest
	6/7/2011	Tomasevic, Nenad	Assignor	Application Publication	13079641 20110245100	Generation Of Antibodies To An Epitope Of Interest Generation Of Antibodies To An Epitope Of Interest
	3/15/2011	Yarranton, Geoffrey T.	Assignor	Application Publication Patent	12975214 20110165172 8642039	Method Of Treating A Staphylococcus Infection In A Patient Having A Low-... Method Of Treating A Staphylococcus Infection In A Patient Having A Low-... Method Of Treating A Staphylococcus Infection In A Patient Having A Low-...
	1/28/2011	Luehrsen, Kenneth	Assignor	Application Publication Patent	12904953 20110123549 8664365	Antibodies to EphA3 Antibodies to EphA3 Antibodies To Epha3
	1/28/2011	Yarranton, Geoffrey T.	Assignor	Application Publication Patent	12904953 20110123549 8664365	Antibodies to EphA3 Antibodies to EphA3 Antibodies To Epha3
	1/28/2011	Martinez, David	Assignor	Application Publication Patent	12904953 20110123549 8664365	Antibodies to EphA3 Antibodies to EphA3 Antibodies To Epha3
	1/28/2011	Bebbington, Christopher R.	Assignor	Application Publication Patent	12904953 20110123549 8664365	Antibodies to EphA3 Antibodies to EphA3 Antibodies To Epha3
	1/28/2011	Yi, Christina	Assignor	Application Publication Patent	12904953 20110123549 8664365	Antibodies To Epha3 Antibodies to EphA3 Antibodies to EphA3
	5/18/2010	Yarranton, Geoffrey T.	Assignor	Application Publication Patent	12718768 20100226930 8834870	Treatment of Leukemias and Chronic Myeloproliferative Diseases with Anti... Treatment of Leukemias and Chronic Myeloproliferative Diseases with Anti... Treatment of Leukemias and Chronic Myeloproliferative Diseases with Anti...
	5/18/2010	Bebbington, Christopher R.	Assignor	Application Publication Patent	12718768 20100226930 8834870	Treatment of Leukemias and Chronic Myeloproliferative Diseases with Anti... Treatment of Leukemias and Chronic Myeloproliferative Diseases with Anti... Treatment of Leukemias and Chronic Myeloproliferative Diseases with Anti...
	5/18/2010	Palath, Varghese	Assignor	Application Publication Patent	12718768 20100226930 8834870	Treatment of Leukemias and Chronic Myeloproliferative Diseases with Anti... Treatment of Leukemias and Chronic Myeloproliferative Diseases with Anti... Treatment of Leukemias and Chronic Myeloproliferative Diseases with Anti...
	5/4/2010	Yarranton, Geoffrey T.	Assignor	Application Publication Patent	12704396 20100215650 8398972	Methods Of Treating Dementia Using A Gm-csf Antagonist Methods Of Treating Dementia Using A Gm-csf Antagonist Methods Of Treating Dementia Using A Gm-csf Antagonist
	5/4/2010	Bebbington, Christopher R.	Assignor	Application Publication Patent	12704396 20100215650 8398972	Methods Of Treating Dementia Using A Gm-csf Antagonist Methods Of Treating Dementia Using A Gm-csf Antagonist Methods Of Treating Dementia Using A Gm-csf Antagonist
	5/4/2010	Palath, Varghese	Assignor	Application Publication Patent	12704396 20100215650 8398972	Methods Of Treating Dementia Using A Gm-csf Antagonist Methods Of Treating Dementia Using A Gm-csf Antagonist Methods Of Treating Dementia Using A Gm-csf Antagonist
	4/28/2010	Yarranton, Geoffrey T.	Assignor	Application Publication	12700599 20100272736	Combination Antibiotic And Antibody Therapy For The Treatment Of Pseudom... Combination Antibiotic And Antibody Therapy For The Treatment Of Pseudom...
	4/28/2010	Baer, Mark	Assignor	Application Publication	12700599 20100272736	Combination Antibiotic And Antibody Therapy For The Treatment Of Pseudom... Combination Antibiotic And Antibody Therapy For The Treatment Of Pseudom...
	4/28/2010	Bebbington, Christopher R.	Assignor	Application Publication	12700599 20100272736	Combination Antibiotic And Antibody Therapy For The Treatment Of Pseudom... Combination Antibiotic And Antibody Therapy For The Treatment Of Pseudom...
	7/13/2009	Luehrsen, Kenneth	Assignor	Application Publication Patent	12431661 20090274706 8168183	Antibodies To Granulocyte-macrophage Colony-stimulating Factor Antibodies To Granulocyte-macrophage Colony-stimulating Factor Antibodies To Granulocyte-macrophage Colony-stimulating Factor
	7/13/2009	Yarranton, Geoffrey T.	Assignor	Application Publication Patent	12431661 20090274706 8168183	Antibodies To Granulocyte-macrophage Colony-stimulating Factor Antibodies To Granulocyte-macrophage Colony-stimulating Factor Antibodies To Granulocyte-macrophage Colony-stimulating Factor
	7/13/2009	Bebbington, Christopher R.	Assignor	Application Publication Patent	12431661 20090274706 8168183	Antibodies To Granulocyte-macrophage Colony-stimulating Factor Antibodies To Granulocyte-macrophage Colony-stimulating Factor Antibodies To Granulocyte-macrophage Colony-stimulating Factor
	6/26/2009	Yarranton, Geoffrey T.	Assignor	Application Publication Patent	12419991 20090263387 8075885	Methods Of Treating Heart Failure Using An Anti-gm-csf Antibody Methods Of Treating Heart Failure Using An Anti-gm-csf Antibody Methods Of Treating Heart Failure Using An Anti-gm-csf Antibody
	6/26/2009	Bebbington, Christopher R.	Assignor	Application Publication Patent	12419991 20090263387 8075885	Methods Of Treating Heart Failure Using An Anti-gm-csf Antibody Methods Of Treating Heart Failure Using An Anti-gm-csf Antibody Methods Of Treating Heart Failure Using An Anti-gm-csf Antibody
	6/18/2009	Kalobios, Inc.	Assignor	Application Application Application Application Publication Publication Publication Publication Patent Patent	11040159 11282107 09764163 10668778 20030165825 20040038317 20050255552 20060134098 7981843 7544477	Circularly Permutated, Interaction-activated Proteins Immunoglobulin variable region cassette exchange Antibody specificity transfer using minimal essential binding determinan... Breakpoint fusion fragment complementation system Circularly Permutated, Interaction-activated Proteins Antibody Specificity Transfer Using Minimal Essential Binding Determinan... Breakpoint fusion fragment complementation system Circularly Permutated, Interaction-activated Proteins Immunoglobulin variable region cassette exchange Antibody specificity transfer using minimal essential binding determinan...
	3/17/2009	Yarranton, Geoffrey T.	Assignor	Application Publication	12354505 20090181020	Methods of Treating Bone-Loss Disorders Using a GM-CSF Antagonist Methods of Treating Bone-Loss Disorders Using a GM-CSF Antagonist
	3/17/2009	Bebbington, Christopher R.	Assignor	Application Publication	12354505 20090181020	Methods of Treating Bone-Loss Disorders Using a GM-CSF Antagonist Methods of Treating Bone-Loss Disorders Using a GM-CSF Antagonist
	1/21/2009	Luehrsen, Kenneth	Assignor	Application Publication Patent	12325806 20090191186 8044181	Antibodies To The Pcrv Antigen Of Pseudomonas Aeruginosa Antibodies To The Pcrv Antigen Of Pseudomonas Aeruginosa Antibodies To The Pcrv Antigen Of Pseudomonas Aeruginosa
	1/21/2009	Yarranton, Geoffrey T.	Assignor	Application Publication Patent	12325806 20090191186 8044181	Antibodies To The Pcrv Antigen Of Pseudomonas Aeruginosa Antibodies To The Pcrv Antigen Of Pseudomonas Aeruginosa Antibodies To The Pcrv Antigen Of Pseudomonas Aeruginosa
	1/21/2009	Baer, Mark	Assignor	Application Publication Patent	12325806 20090191186 8044181	Antibodies To The Pcrv Antigen Of Pseudomonas Aeruginosa Antibodies To The Pcrv Antigen Of Pseudomonas Aeruginosa Antibodies To The Pcrv Antigen Of Pseudomonas Aeruginosa
	1/21/2009	Bebbington, Christopher R.	Assignor	Application Publication Patent	12325806 20090191186 8044181	Antibodies To The Pcrv Antigen Of Pseudomonas Aeruginosa Antibodies To The Pcrv Antigen Of Pseudomonas Aeruginosa Antibodies To The Pcrv Antigen Of Pseudomonas Aeruginosa
	7/28/2008	Yarranton, Geoffrey T.	Assignor	Application Publication Patent	12045589 20080286272 8637016	EphA3 Antibodies for the Treatment of Solid Tumors EphA3 Antibodies for the Treatment of Solid Tumors EphA3 Antibodies for the Treatment of Solid Tumors
	7/28/2008	Bebbington, Christopher R.	Assignor	Application Publication Patent	12045589 20080286272 8637016	EphA3 Antibodies for the Treatment of Solid Tumors EphA3 Antibodies for the Treatment of Solid Tumors EphA3 Antibodies for the Treatment of Solid Tumors
	4/22/2008	Yarranton, Geoffrey T.	Assignor	Application Publication	11944162 20080206241	Methods of Treating Chronic Inflammatory Diseases Using a GM-CSF Antagon... Methods of Treating Chronic Inflammatory Diseases Using a GM-CSF Antagon...
	4/22/2008	Bebbington, Christopher R.	Assignor	Application Publication	11944162 20080206241	Methods of Treating Chronic Inflammatory Diseases Using a GM-CSF Antagon... Methods of Treating Chronic Inflammatory Diseases Using a GM-CSF Antagon...
	3/14/2008	Yarranton, Geoffrey T.	Assignor	Application Publication	11937179 20080171038	Methods Of Treating Idiopathic Thrombocytopenia Purpura Using A Gm-csf A... Methods Of Treating Idiopathic Thrombocytopenia Purpura Using A Gm-csf A...
	3/14/2008	Bebbington, Christopher R.	Assignor	Application Publication	11937179 20080171038	Methods Of Treating Idiopathic Thrombocytopenia Purpura Using A Gm-csf A... Methods Of Treating Idiopathic Thrombocytopenia Purpura Using A Gm-csf A...
	11/14/2005	Yarranton, Geoffrey T.	Assignor	Application Publication Patent	11273906 20070020685 8211648	Secretion Of Antibodies Without Signal Peptides From Bacteria Secretion Of Antibodies Without Signal Peptides From Bacteria Secretion Of Antibodies Without Signal Peptides From Bacteria
	11/14/2005	Bebbington, Christopher R.	Assignor	Application Publication Patent	11273906 20070020685 8211648	Secretion Of Antibodies Without Signal Peptides From Bacteria Secretion Of Antibodies Without Signal Peptides From Bacteria Secretion Of Antibodies Without Signal Peptides From Bacteria

97 Rows Total

	Date Recorded	Party	Role	Document Type	Document No.	Image
	1/26/2005	Kalobios, Inc.	Assignor	Trademark	3335614
	1/26/2005	Kalobios, Inc.	Assignor	Application	76418245
	5/24/2016	Black Horse Capital Master Fund Ltd.	Assignee	Application	77535278
	5/24/2016	Black Horse Capital Master Fund Ltd.	Assignee	Trademark	3415537
	5/24/2016	Black Horse Capital Master Fund Ltd.	Assignee	Application	78361291
	5/24/2016	Black Horse Capital Master Fund Ltd.	Assignee	Trademark	3412618
	5/24/2016	Black Horse Capital Master Fund Ltd.	Assignee	Application	78361294
	5/24/2016	Black Horse Capital Master Fund Ltd.	Assignee	Trademark	4225892
	5/24/2016	Black Horse Capital Master Fund Ltd.	Assignee	Trademark	3335614
	5/24/2016	Black Horse Capital Master Fund Ltd.	Assignee	Application	77535239
	5/24/2016	Black Horse Capital Master Fund Ltd.	Assignee	Application	76418245
	5/24/2016	Black Horse Capital Master Fund Ltd.	Assignee	Trademark	4289244
	1/5/2017	Black Horse Capital Master Fund Ltd.	Assignee	Application	78361291
	1/5/2017	Black Horse Capital Master Fund Ltd.	Assignee	Trademark	3412618
	1/5/2017	Black Horse Capital Master Fund Ltd.	Assignee	Application	78361294
	1/5/2017	Black Horse Capital Master Fund Ltd.	Assignee	Trademark	4225892
	1/5/2017	Black Horse Capital Master Fund Ltd.	Assignee	Trademark	3335614
	1/5/2017	Black Horse Capital Master Fund Ltd.	Assignee	Application	77535239
	1/5/2017	Black Horse Capital Master Fund Ltd.	Assignee	Application	76418245
	1/5/2017	Black Horse Capital Master Fund Ltd.	Assignee	Trademark	4289244
	1/5/2017	Black Horse Capital Master Fund Ltd.	Assignee	Application	77535278
	1/5/2017	Black Horse Capital Master Fund Ltd.	Assignee	Trademark	3415537
	10/17/2018	Humanigen, Inc.	Assignee	Application	77535239
	10/17/2018	Humanigen, Inc.	Assignee	Trademark	4289244
	10/17/2018	Humanigen, Inc.	Assignee	Application	77535278
	10/17/2018	Humanigen, Inc.	Assignee	Trademark	4225892

26 Rows Total

Corporate Family (58)

Track Corporate Family

• 5am Partners, LLC, None
• 5am Ventures LLC, None
• Alloy Ventures 2000, LLC, None
• Anthion Partners II LLC, None
• Baffi, Robert, None
• Barliant Ronald, None
• Baxter International, Inc., None
• Biestek, Marek, None
• Black Horse Capital Management LLC, None
• Black Horse Capital, LP, None
• Boehm Rainer J., None
• Buxton Cheryl, None
• Chappell, Dale, None
• Chase Anthony R, None
• Cooper Jeffrey H, None
• Cross Herb, None
• Development Bank Of Japan, None
• Durrant, Cameron, None
• Edward P. Jordan, None
• Fernandez Thomas Edward, None
• Friedberg Ezra M, None
• GBS Bioventures II A/C, None
• Gilbert Denise, None
• Harrison Michael Wayne, None
• Healy, James, None
• Henner Dennis, None
• Hohneker John, None
• Jester J Gregory, None
• Joseph, Donald, None
• Kilcoyne Adrian, None
• Lam Morgan, None
• Lawlis V Bryan, None
• Lehman Brothers Holdings Inc. Plan Trust, None
• Lehman Brothers Holdings, Inc., None
• Love Ted W, None
• Lyons Gary A, None
• Martell Ron, None
• Mitsubishi UFJ Capital II, Limited Partnership, None
• Molfino, Nestor, None
• Moradi David, None
• Morris Timothy E, None
• Mpm Bioventures Iii, LP, None
• Nomis Bay Ltd., None
• Powell, Michael, None
• Pritchard, David, None
• Sanofi-Synthelabo SA, None
• Savage Robert G, None
• Shkreli, Martin, None
• Shochat, Dan, None
• Singapore Bio Innovations Pte Ltd, None
• Smaldone Alsup Laurie, None
• Smith Brigitte, None
• Steinmetz, Michael, None
• Tousley David L, None
• Withy, Raymond M., None
• Witter Dean III, None
• Xie Yili Kevin, None
• Yarranton, Geoffrey Thomas, None

Subsidiaries

• Healy, James
• 5am Ventures LLC
• Smith Brigitte
• GBS Bioventures II A/C
• Singapore Bio Innovations Pte Ltd
• Lehman Brothers Holdings, Inc.
• Powell, Michael
• Development Bank Of Japan
• Baxter International, Inc.
• Mitsubishi UFJ Capital II, Limited Partnership
• 5am Partners, LLC
• Alloy Ventures 2000, LLC
• Sanofi-Synthelabo SA
• Henner Dennis
• Mpm Bioventures Iii, LP
• Steinmetz, Michael
• Yarranton, Geoffrey Thomas
• Cooper Jeffrey H
• Molfino, Nestor
• Pritchard, David
• Withy, Raymond M.
• Love Ted W
• Lyons Gary A
• Gilbert Denise
• Joseph, Donald
• Lawlis V Bryan
• Cross Herb
• Smaldone Alsup Laurie
• Baffi, Robert
• Martell Ron
• Shkreli, Martin
• Anthion Partners II LLC
• Biestek, Marek
• Moradi David
• Harrison Michael Wayne
• Fernandez Thomas Edward
• Barliant Ronald
• Durrant, Cameron
• Lam Morgan
• Friedberg Ezra M
• Morris Timothy E
• Chappell, Dale
• Tousley David L
• Nomis Bay Ltd.
• Jester J Gregory
• Boehm Rainer J.
• Savage Robert G
• Buxton Cheryl
• Black Horse Capital Management LLC
• Edward P. Jordan
• Lehman Brothers Holdings Inc. Plan Trust
• Shochat, Dan
• Chase Anthony R
• Witter Dean III
• Black Horse Capital, LP
• Kilcoyne Adrian
• Hohneker John
• Xie Yili Kevin

Sign in to add additional links.

Incoming Payments

This organization has not disclosed any incoming payments from lobbying groups.

Outgoing Payments

This organization has not disclosed any outgoing payments to lobbying groups.